Business Standard

Monday, December 23, 2024 | 05:13 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Pfizer vaccine not coming to India soon as trials yet to be conducted

Pfizer has not yet applied for holding clinical trials on Indian volunteers

vaccination
Premium

AstraZeneca-Oxford vaccine is being tested in a phase-3 trial on over 1,600 subjects in India by Serum Institute

Sohini Das Mumbai
While the UK government has cleared Pfizer-BioNTech's mRNA vaccine for use in public, the same is unlikely to be available anytime soon in India.
 
For one, US giant Pfizer’s India arm has not yet applied for conducting clinical trials here, according to sources, and secondly, the vaccine has stringent temperature requirements (-75 degree Celsius), which make it unviable for cold-chain logistics in India.
 
A government official in the know indicated that Pfizer has not yet applied for holding clinical trials on Indian volunteers, as is a pre-requisite for the regulator here to give authorisation to a particular investigational

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in